Center for Technology Transfer & Commercialization (CTTC) Archive — Page 2 of 2

Electrical circuit with various components interfaced with a brain
December 6, 2016

Blood-brain barrier on a chip sheds new light on “silent killer”

A new microfluidic device containing human cells that faithfully mimics the behavior of the blood-brain barrier is providing new insights into brain inflammation, the silent killer.

Silhouetted person wearing a backpack and looking through binoculars while standing on a grassy ridge against an orange sky.
May 5, 2016

Current cancer drug discovery method flawed: VUMC study

The primary method used to test compounds for anti-cancer activity in cells is flawed, Vanderbilt University researchers reported May 2 in Nature Methods.

Portrait of Robert Grajewski wearing a blue suit and checked shirt, set against a dark Vanderbilt University patterned background.
February 1, 2016

Successful entrepreneur and innovator chosen to lead new Innovation Center

Startup veteran Robert Grajewski has been chosen as the inaugural executive director of the newly created Vanderbilt University Innovation Center.

October 22, 2015

VU-invented wireless ECG system receives FDA approval

A wireless electrocardiogram (ECG) system invented at Vanderbilt University and marketed by a Nashville company, InvisionHeart, has received U.S. Food and Drug Administration (FDA) approval.

Five researchers pose together in a bright university building, with one wearing a white lab coat and the others in business-casual clothing.
October 1, 2015

Collaboration seeks to develop new therapies for bone, other diseases

La Jolla Pharmaceutical Co. and Vanderbilt University have signed a research and license agreement covering Vanderbilt’s research program and intellectual property rights related to compounds that block bone morphogenetic protein (BMP) type-I receptors. The compounds have therapeutic potential in a broad range of diseases, including rare genetic disorders.

Seven members of the First Diagnostics team pose outside a building, including Elizabeth Conrad, Michael Feldkamp, Hailey Verano, Samantha Sarett, Lawrence Marnett, Md. Jashim Uddin, and team leader Kelsey Beavers.
April 16, 2015

‘Challenge’ puts technology transfer ingenuity on display

A strategy for commercializing a potential new test for colon cancer that can make tumor cells “glow” won top honors at last week’s TechVenture Challenge.